Ihle JN - Search Results

1

Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.

Chao JR, Parganas E, Boyd K, Hong CY, Opferman JT, Ihle JN. Chao JR, et al. Among authors: ihle jn. Nature. 2008 Mar 6;452(7183):98-102. doi: 10.1038/nature06604. Epub 2008 Feb 20. Nature. 2008. PMID: 18288109

2

Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2.

Funakoshi-Tago M, Pelletier S, Matsuda T, Parganas E, Ihle JN. Funakoshi-Tago M, et al. Among authors: ihle jn. EMBO J. 2006 Oct 18;25(20):4763-72. doi: 10.1038/sj.emboj.7601365. Epub 2006 Oct 5. EMBO J. 2006. PMID: 17024180 Free PMC article.

3

SOCS3 regulates the plasticity of gp130 signaling.

Lang R, Pauleau AL, Parganas E, Takahashi Y, Mages J, Ihle JN, Rutschman R, Murray PJ. Lang R, et al. Among authors: ihle jn. Nat Immunol. 2003 Jun;4(6):546-50. doi: 10.1038/ni932. Epub 2003 May 18. Nat Immunol. 2003. PMID: 12754506

4

Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling.

Gingras S, Parganas E, de Pauw A, Ihle JN, Murray PJ. Gingras S, et al. Among authors: ihle jn. J Biol Chem. 2004 Dec 24;279(52):54702-7. doi: 10.1074/jbc.M411043200. Epub 2004 Oct 18. J Biol Chem. 2004. PMID: 15491990 Free article.

5

Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP).

Gingras S, Pelletier S, Boyd K, Ihle JN. Gingras S, et al. Among authors: ihle jn. PLoS One. 2007 Aug 29;2(8):e808. doi: 10.1371/journal.pone.0000808. PLoS One. 2007. PMID: 17726538 Free PMC article.

6

Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity.

Funakoshi-Tago M, Pelletier S, Moritake H, Parganas E, Ihle JN. Funakoshi-Tago M, et al. Among authors: ihle jn. Mol Cell Biol. 2008 Mar;28(5):1792-801. doi: 10.1128/MCB.01447-07. Epub 2007 Dec 26. Mol Cell Biol. 2008. PMID: 18160720 Free PMC article.

7

The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer.

Schuendeln MM, Piekorz RP, Wichmann C, Lee Y, McKinnon PJ, Boyd K, Takahashi Y, Ihle JN. Schuendeln MM, et al. Among authors: ihle jn. Mol Cell Biol. 2004 Jul;24(14):6403-9. doi: 10.1128/MCB.24.14.6403-6409.2004. Mol Cell Biol. 2004. PMID: 15226440 Free PMC article.

8

SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation.

Takahashi Y, Carpino N, Cross JC, Torres M, Parganas E, Ihle JN. Takahashi Y, et al. Among authors: ihle jn. EMBO J. 2003 Feb 3;22(3):372-84. doi: 10.1093/emboj/cdg057. EMBO J. 2003. PMID: 12554639 Free PMC article.

9

Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5.

Bertolino E, Reddy K, Medina KL, Parganas E, Ihle J, Singh H. Bertolino E, et al. Nat Immunol. 2005 Aug;6(8):836-43. doi: 10.1038/ni1226. Epub 2005 Jul 17. Nat Immunol. 2005. PMID: 16025120

10

Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, McKinnon PJ, Cleveland JL, Zambetti GP. Jeffers JR, et al. Among authors: ihle jn. Cancer Cell. 2003 Oct;4(4):321-8. doi: 10.1016/s1535-6108(03)00244-7. Cancer Cell. 2003. PMID: 14585359 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters